Cardiovascular Genetics and Genomics

CVG&G_CoverInternational Journal for applied and translational genetic and genomic approaches to cardiovascular medicine and surgery

Editor in Chief: Professor Dhavendra Kumar, MD FRCP FRCPCH FACMG
Consultant in Clinical Genetics/ Cardiovascular Genetics Institute of Cancer and Genetics Cardiff University School of Medicine University Hospital of Wales, Cardiff, UK and The Genomic Policy Unit Faculty of Life Sciences and Education The University of South Wales, UK

‘Cardiovascular Genetics and Genomics’ is an open-access online journal publishing original research, meta analyses, reviews, case commentaries and updates on recent development focusing on genetic and genomic aspects of wide range of cardiovascular conditions. The journal particularly focuses on delineation of the clinical phenotypes, new genes and variants, genotype-phenotype correlations, basic and clinically applied molecular genetics, next generation sequencing and new therapeutic developments (drugs & devices). The original cardiovascular research will highlight the omics: proteomics, metabolomics, functional genomics and systems biology – as well as clinical trials in the burgeoning field of pharmacogenomics related to cardiovascular medicine. The journal also features current and comprehensive reviews in the areas of recent advances in cardiovascular development, Mendelian cardiovascular conditions, new diagnostic and therapeutic progress, and controversies in cardiovascular genetics. A dedicated news section summarizes the new developments in the field, highlighting articles likely to impact the management of cardiovascular disorders. Other features include clinical case reports and studies, book reviews, and letters to the editor. The following categories (not limited) of papers and articles are published in Cardiovascular Genetics & Genomics:

  • Cardiovascular development
  • Congenital heart disease
  • Inherited cardiomyopathy-Hypertrophic cardiomyopathy (HCM), Dilated cardiomyopathy, Arryhthmogenic right ventricular cardiomyopathy (ARVC)
  • Cardiovascular genes- Sarcomere, cytoskeletal, junctional, ion channel and others
  • Inherited arrhythmia- Long QT Syndrome (LQTS); Short QT Syndrome Brugada syndrome, Catecholaminergic polymorphic ventricular tachycardia (CPVT)
  • Inherited vascular/ connective diseases: Marfan syndrome, Loeys-Dietz syndrome, Ehlers-Danlos syndrome and other connective tissue diseases with cardiovascular phenotypes
  • Hypertension- systemic and pulmonary arterial
  • Inherited metabolic disease with cardiovascular phenotypes
  • Sudden unexplained/cardiac death (infant and adult)
  • Inherited neuromuscular disorders with cardiovascular phenotypes
  • Complex cardiovascular disease (coronary artery disease; hypertension)
  • Molecular cardiology- diagnostic, experimental, applied and translational
  • Cardiovascular pharmacogenetics & pharmacogenomics
  • Bio-banking and cardiovascular genomics databases
  • Gene, Stem cell and somatic cell therapy in cardiovascular diseases
  • Surgical and non-invasive therapy for inherited cardiovascular conditions
  • Education and training in cardiovascular genetics and genomics
  • Ethical, legal, social issues related to cardiovascular genetics and genomics

Submission of manuscripts: Manuscripts of original research papers, review articles, commentaries and opinions and conference reports are invited for publication in Cardiovascular Genetics and Genomics. All manuscripts should be submitted online as an email attachment to Only commonly used word processing software should be used for example Microsoft Word, Adobe, Rich Text etc. All manuscripts should follow the usual format and include: the title, authors, institute affiliations, name/address of the corresponding author, selection of search engine key words (not more than 10), name/ address of relevant ethical approval authority, declaration on conflict of interest, statement on commercial/ financial benefits and copyright authorization for any illustrations, tables or part of the text included in the manuscript. References should be cited in the text with author and year; use suffix et al for more than 2 authors in the reference cited. All references should be listed in alphabetical order. Name of the soft ware reference manager should be indicated in the manuscript. All manuscripts are independently peer-reviewed and final decision is made by the editor in chief reflecting views of the lead- editor (usually a member of the editorial board or a guest editor) and external reviewers. One of the following decisions will be notified to the corresponding author- Accept, Accept subject to major revision, Accept subject to minor revision, Reject without peer review, Reject following peer review. All accepted manuscripts are published (online and print) subject to copyright agreement with the publishers (see below). The journal is open-access and a charge is applicable. The tariff is available on request and specific charge will be advised on acceptance of the manuscript. However, the open access charge could be waived in exceptional circumstances, for example an invited review or commentary authorized by the editor in chief. The open access charge may also be waived or discounted on voluntary and for an individual publication. All paid or waived open-access publications would be made available to all registered readers. Any reader may access the paper or article subject to a small downloading fee advised at the time of consumer registration. Corporate information: ‘Cardiovascular Genetics and Genomics’ is published by The Genomic Medicine Foundation (UK) Ltd, a not-for-profit company registered in England and Wales (Registered Number 8749919). The publisher holds all legal rights and acquires all financial or any other benefits of any published material in the journal. For all enquiries and information please visit or contact direct Professor Dhavendra Kumar, the Editor in Chief (